Navigation Links
Collaborative Drug Discovery 2nd Annual Community Meeting - Oct. 7, 2008, Speakers Confirmed & Call for Posters

BURLINGAME, Calif., July 31 /PRNewswire/ -- Collaborative Drug Discovery invites you to submit your poster presentation and register at to attend the 2nd Annual CDD Community Meeting (a free, 1-day event) on October 7th. The CDD Community Meeting is the best place for the CDD community and all scientists to get together, discuss their research projects, and showcase their work to others in the community.

Early List of Confirmed Speakers:

-- David Sullivan, MD, Johns Hopkins

-- Fred Buckner MD, University of Washington

-- Janice Kranz, PhD, Stanley Center for Psychiatric Research, Broad

Institute of MIT & Harvard

-- Conor Caffrey, PhD, Sandler Center, UCSF

-- Jean Claude-Bradley, PhD Dept. of Chemistry, Drexel University

-- Sean Ekins, PhD, ex-Pfizer/Lilly Computational Chemist

-- Andrea Altieri, PhD, ASINEX

-- Robert Damoiseaux, PhD, UCLA Molecular Screening Shared Resource (MSSR)


-- Moses Hohman, PhD, Head of Software, Collaborative Drug Discovery (CDD


-- J. Leighton Read, MD (Alloy Ventures) -- Financing Biomedical

Innovation from academia to the market: From FluMist(TM) to Priority

Review Vouchers and other stories

-- Russell "Rusty" Bromley, Chief Operating Officer, Myelin Repair


Timely panel topics:

-- Panel #1: What Foundations are looking for from Academic researchers?

-- Panel #2: What makes collaborations successful within and between


Who should attend?

-- Scientists working in drug discovery

-- Researchers who are involved in collaborations or generate complex drug

discovery data

-- Students who want to learn more about the drug discovery industry

-- People who wish to network, establish new or strengthen existing


-- Current CDD community members to set the collaborative platform's

future direction

-- Anyone interested in new drugs for diseases of the developing world,

private public partnerships, and/or global health

So register now at to join us on October 7th at the J. David Gladstone Research Institute (UCSF Mission Bay Campus, 1650 Owens Street, San Francisco, CA).

About Collaborative Drug Discovery, Inc.

Collaborative Drug Discovery, Inc. (CDD) -- -- provides web-based software that organizes preclinical research data to help scientists advance new drug candidates more effectively. The CDD database enables scientists to "archive, mine, and collaborate"(R) around preclinical chemical and biological drug discovery data through a web-based interface. The software helps distributed research groups to safely store and intelligently analyze small molecule, enzyme, cell and animal bioactivity data accumulated from both low-throughput and high-throughput screens. Unique collaboration features and CDD's community-oriented approach help unite globally dispersed humanitarian efforts against neglected infectious diseases. Similar collaborative strategies are also rapidly gaining prominence in the commercial arena. CDD offers its industrial-strength database software at a price affordable to academic laboratories, research foundations, and small companies.

SOURCE Collaborative Drug Discovery, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Malaria Vaccine Developer Sanaria Inc. and the University of Maryland Biotechnology Institute Awarded Collaborative, Multi-Year, US $600,000 NIH Phase I Small Business Innovation Research Grant
2. Medpedia Announced, Worlds Largest Collaborative Online Encyclopedia of Medicine and Health
3. Access Granted to Present at the Collaborative Communications Summit: Health Technology Investment Forum
4. Patient Centered Primary Care Collaborative Statement on Passage of Medicare Bill
5. Collaborative Launches Initiative to Protect Rights of Parents with Mental Illnesses
6. American Red Cross and NSF Scrub Club(R) Announce Collaborative Agreement
7. DFG establishes 8 new Collaborative Research Centers
8. Collaborative Drug Discovery and Myelin Repair Foundation Announce Partnership
9. Perrigo Company Announces Collaborative Agreement for Generic Topical Products With Pentech
10. The Leukemia & Lymphoma Society and MannKind Corporation Announce Collaborative Research Agreement
11. Rural Maryland Hospitals Form Unprecedented Collaborative to Improve Patient Care
Post Your Comments:
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on ... Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ability ... fumigation is not a common occurrence, but a necessary one in the event that lice ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Consumers have taken ... regulators/payers have placed more emphasis on patient outcomes. ... support programs in the pharmaceutical industry have evolved ... Consequently, pharmaceutical companies are focusing on becoming more ... providing products and services that improve health. ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... Dublin - ... " Global Markets for Spectroscopy Equipment" report ... This report focuses on the global market of ... applications in various applications. The report deals with spectroscopy ... industries: pharmaceutical and biotechnology, food and beverage, and environmental ...
Breaking Medicine Technology: